Clinical Trial Update: A Phase 1 Study of IPI-926 in Patients With Advanced and/or Metastatic Solid Tumor Malignancies [Phase 1]

View source ↗

Summary

Phase 1 study of IPI-926 in patients with advanced and/or metastatic solid tumor malignancies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• IPI-926 (IPI-926)

Snippet

Sponsor: Infinity Pharmaceuticals, Inc. | Conditions: Neoplasms | Phase 1 | Status: COMPLETED